Efficacy and tolerability of tariquidar in patients with doxorubicin or taxane resistant advanced breast cancer.

Trial Profile

Efficacy and tolerability of tariquidar in patients with doxorubicin or taxane resistant advanced breast cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs Antineoplastics; Tariquidar
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Sponsors QLT
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top